# BRIVARACETAM
> **ANDA220470** · Abbreviated New Drug Application (Generic) · Sponsor: CENTAUR PHARMS PVT · Approved 2026-02-23
## Drug
- **FDA Application Number:** ANDA220470
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BRIVARACETAM
- **Generic name:** Brivaracetam
- **Active ingredients:** BRIVARACETAM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CENTAUR PHARMS PVT
- **First approval:** 2026-02-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220470)
---
*AI Analytics · CC0 1.0*